xxxxxSTEM

xxxxxSTEM Articles

Today’s version of the BioHealth Business Daily is rather different as we have a big disappointment from one of the top biotech operations in the world.  BioHealth stocks moving on news and after...
We are seeing many key movers in the BioHealth space today.  Biotech stocks and drug stocks are often more volatile than other sectors.  Today’s BioHealth Business Daily includes the key moves...
Stem cell stocks (tracked in Tickerspy’s Stem Cell Stock’s Index (*RXSTM) are up over 7% today, led by Athersys Inc (NASDAQ: ATHX).  Athersys Inc. rose as high as 395% this morning...
These are this morning’s top day trader and active trader alert stocks, with more details and analysis over at VSInvestor.com with a link to each story: Geron Corporation (NASDAQ: GERN),...
Tickerspy’s Stem Cell Stock Index (*RSXTM) took off today, rising nearly 13%.  The movement followed a release from the National Institutes of Health  (NIH) announcing that 13 embryonic stem...
Today is an unusually active day for many emerging biotech stocks in the news and we are seeing significant moves in response. We have more detail on each with appropriate links through to more...
Diabetes is becoming an epidemic in the U.S. and the Western World.  The ties to obesity are often direct, so the potential treatments are often directly tied as well.  We did a recent dig down for...
Here are some of the top stories affecting key drug and biotech stocks this Friday.  We also have links through to more detailed coverage and analysis at BioHealthInvestor.com: Biogen Idec Inc....
Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth coverage and analysis today at the website BioHealthInvestor.com: Rigel Pharmaceuticals...
Here are some of the top stories affecting key drug and biotech stocks that are covered in-depth today at BioHealthInvestor.com: Cigna corp. (NYSE: CI), Aetna Inc. (NYSE: AET), and other managed care...
Alnylam (Nasdaq: ALNY) leads a short list of some of the fastest-growing biotech stocks where analyst estimate revisions continue to rise. BioHealth Investor began by analyzing 171 stocks in the...
General Electric Company (NYSE: GE) is taking a bold and controversial new step into the field of embryonic stem cell research.  The company has signed an exclusive license and alliance pact with...
There are some interesting cult stocks which have recovered so much that they are being added into the Russell 3000 Index when the index gets rebalanced and reconstituted at the end of this month. ...
We are seeing massive gap-ups this morning in stem cell stocks. President Obama is signing an executive order that will lift the Bush ban on funding of embryonic stem cell funding. What is...
Good news out of the sector is driving StemCells (STEM) up almost 20%. Details here. DryShips (DRYS) is spiking up on news of the China stimulus package. American Capital (ACAS) suspended its...